Person profile
Address
San Diego, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
FATE THERAPEUTICS INC
11 Jun 24
4
Dare Bioscience, Inc.
7 Jun 24
4
NEUROCRINE BIOSCIENCES INC
23 May 24
4
Regulus Therapeutics Inc.
21 May 24
4
Regulus Therapeutics Inc.
17 May 24
4
NEUROCRINE BIOSCIENCES INC
4 Jan 24
144
NEUROCRINE BIOSCIENCES INC
2 Jan 24
4
Regulus Therapeutics Inc.
14 Aug 23
4
Dare Bioscience, Inc.
21 Jun 23
4
Regulus Therapeutics Inc.
13 Jun 23
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
7 Jun 24 | FATE Fate Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 3.68 | 40,000 | 147.20 k | 40,000 |
5 Jun 24 | DARE Dare Bioscience | Stock Option Common stock | Grant | Acquire A | No | No | 0.43 | 40,000 | 17.20 k | 40,000 |
22 May 24 | NBIX Neurocrine Biosciences | RSU Common Stock | Grant | Acquire A | No | No | 0 | 2,869 | 0.00 | 2,869 |
20 May 24 | RGLS Regulus Therapeutics | Stock Option Common Stock | Grant | Acquire A | Yes | No | 2.01 | 60,000 | 120.60 k | 60,000 |
16 May 24 | RGLS Regulus Therapeutics | Stock Option Common Stock | Grant | Acquire A | Yes | No | 2.01 | 30,000 | 60.30 k | 30,000 |